JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB326417

Human PTEN knockout VCaP cell line

Be the first to review this product! 리뷰 제출

|

(0 출판물)

PTEN KO cell line available to order. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control available. Deletion. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 이미지
Next Generation Sequencing - Human PTEN knockout VCaP cell line (AB326417)
  • NGS

Lab

Next Generation Sequencing - Human PTEN knockout VCaP cell line (AB326417)

133 bp deletion (allele 1) and 134 bp deletion (allele 2) after Pro96 in exon 5 (CCDS31238.1).

Western blot - Human PTEN knockout VCaP cell line (AB326417)
  • WB

Lab

Western blot - Human PTEN knockout VCaP cell line (AB326417)

False colour image of Western blot : Anti-PTEN antibody [Y184] (ab32199) staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH loading control staining, shown in magenta.

In Western blot, ab32199 was shown to bind specifically to PTEN. A band was observed at 47 kDa in Wild-type VCAP cell lysates with no signal observed at this size in PTEN knockout cell line.

Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C.

Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.

Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed at 1 : 10000 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed at 1 : 10000.

All lanes:

Western blot - Anti-PTEN antibody [Y184] (<a href='/ko/products/primary-antibodies/pten-antibody-y184-ab32199'>ab32199</a>) at 1/10000 dilution

Lane 1:

Wild-type VCAP cell lysates

Lane 2:

Western blot - Human PTEN knockout VCaP cell line (ab326417)

Secondary

All lanes:

Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed at 1/10000 dilution

Observed band size: 47 kDa

false

Western blot - Human PTEN knockout VCaP cell line (AB326417)
  • WB

Lab

Western blot - Human PTEN knockout VCaP cell line (AB326417)

False colour image of Western blot : Anti-PTEN antibody [EPR9941] (ab154812) staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH loading control staining, shown in magenta.

In Western blot, ab154812 was shown to bind specifically to PTEN. A band was observed at 47 kDa in Wild-type VCAP cell lysates with no signal observed at this size in PTEN knockout cell line.

Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C.

Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.

Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed at 1 : 10000 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed at 1 : 10000.

All lanes:

Western blot - Anti-PTEN antibody [EPR9941] (<a href='/ko/products/primary-antibodies/pten-antibody-epr9941-ab154812'>ab154812</a>) at 1/10000 dilution

Lane 1:

Wild-type VCAP cell lysates

Lane 2:

Western blot - Human PTEN knockout VCaP cell line (ab326417)

Secondary

All lanes:

Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed at 1/10000 dilution

Observed band size: 47 kDa

false

주요 정보

세포 유형

VCaP

Species or organism

Human

조직

Prostate

Knockout 검증

Next Generation Sequencing,Western blot

Mutation 정보

Deletion

질병

Carcinoma

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

제품 세부 정보

Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab326417-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"Human wild-type VCaP cell line kit component", "number":"AB326417-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"Human PTEN knockout VCaP cell line kit component", "number":"AB326417-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab326417-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"Human PTEN knockout VCaP cell line kit component", "number":"AB326417-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
PTEN
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Next Generation Sequencing, Western blot
배송 시 보관 조건
Dry Ice
적절한 단기 보관 조건
-196°C
적절한 장기 보관 조건
-196°C

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Male

Viability

~ 60%

초기 취급 지침

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes. <br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 280 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution. <br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25. <br>4. Incubate the culture at 37°C incubator with 5% CO.</p> <p>VCaP is a very slow growing cell line and can take up to 48 hours to attach post-thaw and after subcultures. lt can routinely take a minimum of 2 weeks or more for cells to reach approximately 50% confluence with a dense mixture of adherent cells, floating clusters and moderate to heavy debris is always present. The cells may recover better in a T-25 flask compared to a T75 flask. Do not discard any floating cells that may be present during medium changes and subcultures, instead, spin them down using gentle centrifugation and add them back to the adherent population. The cells attach in small tightly formed clusters and some single cells. As the cells attach and start to proliferate and spread, they will grow as flattened epithelial like islands of tightly packed cells.</p>

Subculture 가이드라인
  • Subculture when cell density reaches 1-2x105 cells/mL.
  • A guide seeding density of 2-4x10e4 cells/mL is recommended.
  • All seeding densities should be based on cell counts gained by established methods.
배양 배지

DMEM + 10% FBS

동결보존 배지

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

제품 프로토콜

타겟 정보

See full target information PTEN

대체 명칭 보기

Phosphatase and tensin homolog, Mutated in multiple advanced cancers 1, MMAC1, PTEN, TEP1, Inositol polyphosphate 3-phosphatase

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com